Hydroxyurea and acute painful crises in sickle cell anemia: Effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home

Journal of Pain and Symptom Management

Volumn 40, Issue 6, 2010, Pages 870-882

  Ballas, Samir K ^a   Bauserman, Robert L ^b   McCarthy, William F ^b   Castro, Oswaldo L ^c   Smith, Wally R ^d   Waclawiw, Myron A ^e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

^c HOWARD UNIVERSITY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Hospitalization; Hydroxyurea; Opioid utilization; Painful crisis; Sickle cell anemia

Indexed keywords

BUTORPHANOL; CODEINE; DEXTROPROPOXYPHENE; HYDROCODONE; HYDROMORPHONE; HYDROXYUREA; LEVORPHANOL; METHADONE; MORPHINE; NALBUPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PETHIDINE;

ADULT; ARTICLE; DRUG EFFECT; DRUG UTILIZATION; EMERGENCY CARE; FEMALE; FOLLOW UP; HOME CARE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PAIN; SICKLE CELL ANEMIA; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; DOUBLE-BLIND METHOD; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYUREA; LENGTH OF STAY; MALE; MIDDLE AGED; PAIN; TREATMENT OUTCOME;

EID: 78649928747     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.03.020     Document Type: Article

References (51)

1. S.K. Ballas Pain management of sickle cell disease Hematol Oncol Clin North Am 19 2005 785 802
2. L.J. Benjamin Nature and treatment of the acute painful episode in sickle cell disease M.H. Steinberg, B.G. Forget, D.R. Higgs, D.J. Weatherall, Disorders of hemoglobin: Genetics, pathophysiology, and clinical management 2001 Cambridge University Press New York 671 710
3. S.K. Ballas Current Issues in Sickle Cell Pain and its Management. Hematology 2007, American Society of Hematology Education Program Book 2007 American Society of Hematology Washington, DC 97-105
4. S.K. Ballas Sickle cell anemia. PIER Module of the American College of Physicians Available from http://pier.acponline.org Accessed June 2009
5. L.J. Benjamin, and R. Payne Pain in sickle cell disease: a multidimensional construct B. Pace, Renaissance of sickle cell disease research in the genomic era 2007 Imperial College Press London, UK 99 118
6. S.K. Ballas Sickle cell pain. Progress in pain research and management vol. 11 1998 IASP Press Seattle, WA
7. L.J. Benjamin, C.D. Dampier, and A. Jacox Guideline for the management of acute and chronic pain in sickle cell disease. American Pain Society Clinical Practice Guidelines Series No. 1 1999 American Pain Society Glenview, IL
8. W.R. Smith, L.T. Penberthy, and V.E. Bovbjerg Daily assessment of pain in adults with sickle cell disease Ann Intern Med 148 2008 94 101
9. P. Nicola, F. Sorrentino, L. Scaramucci, P. de Fabritiis, and P. Cianculli Pain syndromes in sickle cell disease: an update Pain Med 10 2009 470 480
10. E.P. Orringer, J.F. Casella, and K.I. Ataga Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial JAMA 286 2001 2099 2106
11. V.L. Gupta, and B.S. Chaubey Efficacy of zinc therapy in prevention of crisis in sickle cell anemia: a double blind, randomized controlled clinical trial J Assoc Physicians India 43 1995 467 469
12. K. Anie, A. Steptos, and D. Bevan Sickle cell disease: pain, coping and quality of life in a study of adults in the UK Br J Health Psychol 7 2002 331 344 (Pubitemid 34975967)
13. K. Gil, J. Carter, L. Peter, C. Scipio, and S. Bediako Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle cell disease Health Psychol 23 2004 267 274
14. D. McClish, J. Levenson, and L. Penberthy Gender differences in pain and healthcare utilization for adult sickle cell disease patients: the PiSCES project J Womens Health 15 2006 146 154
15. D. McClish, L. Penberthy, and V. Bovbjerg Health related quality of life in sickle cell patients: the PiSCES project Health Qual Life Outcomes 3 2005 50
16. E. Perlin, H. Finke, and O. Castro Treatment of sickle cell pain crisis: a clinical trial of diflunisal (Dolobid) Clin Trials J 25 1988 254 264
17. E. Perlin, H. Finke, and O. Castro Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis Am J Hematol 46 1994 43 47
18. E.R. Gonzalez, J.P. Ornato, D. Ware, D. Bull, and R.P. Evens Comparison of intramuscular analgesic activity of butorphanol and morphine in patients with sickle cell disease Ann Emerg Med 18 1989 603 605
19. J. Elander, and A. Midence A review of evidence about factors affecting quality of pain management in sickle cell disease Clin J Pain 12 1996 180 193
20. L. Shaiova, and D. Wallenstein Outpatient management of sickle cell pain with chronic opioid pharmacotherapy J Natl Med Assoc 96 2004 1 3
21. L.R. Solomon Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void Blood 111 2008 997 1003
22. S. Charache, M.L. Terrin, R.D. Moore The Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia N Engl J Med 332 1995 1317 1322
23. D.R. Powars, J.N. Weiss, L.S. Chan, and W.A. Schroeder Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood 63 1984 921 926
24. H. Valafar, F. Valafar, and A. Darvill Predicting the effectiveness of hydroxyurea in individual sickle cell patients Artif Intell Med 18 2000 133 148
25. th ed. 2002 NIH Bethesda, MD
26. S.K. Ballas, J. Larner, and E.D. Smith Rheologic predictors of the severity of the painful sickle cell crisis Blood 72 1988 1216 1223
27. S.K. Ballas The sickle cell painful crisis in adults: phases and objective signs Hemoglobin 19 1995 323 333
28. S. Lanzkron, C. Haywood Jr., J.B. Segal, and G.J. Dover Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea Am J Hematol 81 2006 927 932
29. S.K. Ballas, and E.D. Smith Red cell changes during the evolution of the sickle cell painful crisis Blood 79 1992 2154 2163
30. E.A. Manci, D.E. Culberson, and Y.M. Yang Causes of death in sickle cell disease: an autopsy study Br J Haematol 123 2003 359 365
31. E.P. Vichinsky, L.D. Neumayr, and A.N. Earles Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group N Engl J Med 342 2000 1855 1865
32. S.K. Ballas, and M.J. Marcolina Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia Transfusion 46 2006 105 110
33. J. Panepinto, D. Brousseau, and C. Hillery Variation in hospitalization and hospital length of stay in children with vaso-occlusive crisis in sickle cell disease Pediatr Blood Cancer 44 2005 182 186
34. M.A. Ellison, and H. Bouchner Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease J Natl Med Assoc 99 2007 192 196
35. S.K. Ballas, and M. Lusardi Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance Am J Hematol 79 2005 17 25
36. M.J. Frei-Jones, J.J. Field, and M.R. DeBaun Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease Pediatr Blood Cancer 52 2009 481 485
37. H. Davis, R.M. Moore Jr., and P.J. Gergen Cost of hospitalizations associated with sickle cell disease in the United States Public Health Rep 112 1997 40 43 (Pubitemid 27053113)
38. A.M. Epstein Revisiting readmissions - changing the incentives for shared accountability N Engl J Med 360 2009 1457 1459
39. R.D. Moore, S. Charache, F. Barton, S.K. Ballas, and M. Terrin Cost-effectiveness of hydroxyurea in sickle cell anemia Am J Hematol 64 2000 26 31
40. S.K. Ballas The cost of health care for patients with sickle cell disease Am J Hematol 84 2009 320 322
41. M.H. Steinberg, F. Barton, and O. Castro Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment JAMA 289 2003 1645 1651
42. S.K. Ballas Meperidine for acute sickle cell pain in the emergency department: revisited controversy Ann Emerg Med 51 2008 217
43. M.T. Morgan Use of meperidine as the analgesic of choice in treating pain from acute painful sickle cell crisis Ann Emerg Med 51 2008 202 203
44. Howland MA. Why meperidine should not make a comeback in treating patients with sickle cell disease. 2008; 21:203-205.
45. D.L. Tobin, K.A. Holroyd, R.V. Reynolds, and J.K. Wigal The hierarchical factor structure of the Coping Strategies Inventory Cognit Ther Res 13 1989 343 361
46. S. Nadvi, S. Sarnaik, and Y. Ravindranath Low frequency of meperidine associated seizures in sickle cell disease Clin Pediatr (Phila) 38 1999 459 462
47. E.A. Kopecky, S. Jacobson, P. Joshi, and G. Konen Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease Clin Pharmacol Ther 75 2004 140 146
48. I.D. Buchanan, M. Woodward, and G.W. Reed Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome Pediatr Blood Cancer 45 2005 716 724
49. M.L. Weber, R.P. Hebbel, and K. Gupta Morphine induces kidney injury in transgenic sickle cell mice [abstract] Blood 106 2005 884a 885a
50. S.K. Ballas, F.B. Barton, and M.A. Waclawiw Hydroxyurea and sickle cell anemia: effect on quality of life Health Qual Life Outcomes 4 2006 59
51. M.H. Steinberg, W.F. McCarthy, and O. Castro The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up Am J Hematol 85 2010 403 408